1,748
Views
39
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Hemolysis indexes for biochemical tests and immunoassays on Roche analyzers: Determination of allowable interference limits according to different calculation methods

, , , , , , , , , , , & show all
Pages 162-169 | Received 17 Aug 2014, Accepted 27 Nov 2014, Published online: 22 Jan 2015

References

  • Carraro P, Plebani M. Errors in a stat laboratory: types and frequencies 10 years later. Clin Chem 2007;53: 1338–42.
  • Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002;48:691–8.
  • Plebani M, Lippi G. To err is human. To misdiagnose might be deadly. Clin Biochem 2010;43:1–3.
  • Carraro P, Servidio G, Plebani M. Hemolyzed specimens: a reason for rejection or a clinical challenge? Clin Chem 2000;46:306–7.
  • Lippi G, Cervellin G, Mattiuzzi C. Critical review and meta-analysis of spurious hemolysis in blood samples collected from intravenous catheters. Biochem Med 2013;23: 193–200.
  • Tiwari AK, Pandey P, Dixit S, Raina V. Speed of sample transportation by a pneumatic tube system can influence the degree of hemolysis. Clin Chem Lab Med 2011;50:471–4.
  • Ji JZ, Meng QH. Evaluation of the interference of hemoglobin, bilirubin, and lipids on Roche Cobas 6000 assays. Clin Chim Acta 2011;412:1550–3.
  • Szoke D, Braga F, Valente C, Panteghini M. Hemoglobin, bilirubin, and lipid interference on Roche Cobas 6000 assays. Clin Chim Acta 2012;413:339–41; author reply 42–3.
  • Dolci A, Panteghini M. Harmonization of automated hemolysis index assessment and use: is it possible? Clin Chim Acta 2014;432:38–43.
  • Clinical and Laboratory Standards Institute (CLSI). Interference testing in clinical chemistry: Approved guidelines. 2nd. CLSI document EP7-A2. Wayne, PA: CLSI; 2005.
  • Sanderink GJ, van Rijn HJ. Quantitative measurement of plasma hemoglobin by second derivative spectrophotometry. Clin Chim Acta 1985;146:65–73.
  • French Society of Clinical Biology. Commission for validation of methods. Ann Biol Clin 1986;44:679–755.
  • Petrova DT, Cocisiu GA, Eberle C, Rhode KH, Brandhorst G, Walson PD, Oellerich M.Can the Roche hemolysis index be used for automated determination of cell-free hemoglobin? A comparison to photometric assays. Clin Biochem 2013;46: 1298–301.
  • Ryder KW, Trundle DS, Bode MA, Cole RE, Moorehead WR, Glick MR. Effects of hemolysis, icterus, and lipemia on automated immunoassays. Clin Chem 1991;37:1134–5.
  • Ricós C, Cava F, García-Lario JV, Hernández A, Iglesias N, Jiménez CV, Minchinela J, Perich C, Simón M, Domenech MV, Alvarez V. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest 2004;64:175–84.
  • Harris EK, Yasaka T. On the calculation of a “Reference change” For comparing two consecutive measurements. Clin Chem 1983;29:25–30.
  • Ricós C, Alvarez V, Cava F, Garcia-Lario JV, Hernández A, Jimenez CV, Minchinela J, Perich C, Simón M. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59:491–500. Updated database available on http://www.westgard.com/biodatabase1.htm (accessed in March, 2014).
  • Dimeski G. Interference testing. Clin Biochem Rev 2008;29(Suppl. 1):S43–8.
  • Glick MR, Ryder KW, Jackson SA. Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 1986;32:470–5.
  • Snyder JA, Rogers MW, King MS, Phillips JC, Chapman JF, Hammett-Stabler CA. The impact of hemolysis on Ortho-Clinical Diagnostic's ECI and Roche's Elecsys immunoassay systems. Clin Chim Acta 2004;348:181–7.
  • Florkowski C, Wallace J, Walmsley T, George P. The effect of hemolysis on current troponin assays – a confounding preanalytical variable? Clin Chem 2010;56:1195–7.
  • Lippi G, Banfi G, Buttarello M, Ceriotti F, Daves M, Dolci A, Caputo M, Giavarina D, Montagnana M, Miconi V, Milanesi B, Mosca A, Morandini M, Salvagno GL. Recommendations for detection and management of unsuitable samples in clinical laboratories. Clin Chem Lab Med 2007;45:728–36.
  • Clinical and Laboratory Standards Institute (CLSI). Hemolysis, icterus, and lipemia/turbidity as indicators of interference in clinical laboratory analysis; Approved guidelines. CLSI document C56-A. Wayne, PA: CLSI; 2012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.